Ads
related to: breast cancer, drugmaker- Dosing & Administration
Download The Dosing Guide To Learn
About A MBC Treatment Option.
- Efficacy & Safety Data
See If A MBC Treatment
Is An Option For Your Patients.
- MBC Treatment Option
For Eligible Patients With
Previously Treated MBC. Learn More.
- MBC Info
Identifying Targetable
Populations Is Critical. Learn More
- Dosing & Administration
Search results
Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
Reuters via Yahoo Finance· 1 year agoNovartis breast cancer drug Kisqali cut the risk of recurrence by more than 25% in a pivotal trial...
Seagen's breast cancer therapy succeeds in late-stage study
Reuters via Yahoo News· 10 months agoPfizer in March agreed to acquire Seagen and its targeted therapies in a $43 billion deal to help...
AstraZeneca and Daiichi's breast cancer drug meets goal in study
Reuters via Yahoo News· 9 months agoBy Maggie Fick (Reuters) -AstraZeneca said on Friday its experimental precision drug had slowed the...
US FDA approves AstraZeneca's breast cancer drug combination
Reuters via Yahoo News· 7 months agoThe FDA decision allows use of the drug, chemically known as capivasertib, in combination with the...
Lung cancer deaths cut in half with AstraZeneca pill, large trial finds
NBC News via Yahoo News· 1 year agoA once-daily pill from drugmaker AstraZeneca cut deaths in half among a subset of early-stage lung...
Novartis buoyed by trial success in early-stage breast cancer
Reuters via Yahoo News· 1 year agoFRANKFURT (Reuters) -Novartis's Kisqali breast cancer drug cut the risk of recurrence in women who...
New Cancer 'Missile' Drugs May Be More Effective Than Traditional Chemotherapy
Verywell Health via Yahoo News· 1 month agoIllustration by Julie Bang for Verywell Health Fact checked by Nick Blackmer Key Takeaways The FDA...
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
Investor's Business Daily· 1 month agoAstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after...
AstraZeneca experimental drug meets main goals of breast cancer study
Reuters via Yahoo News· 2 years ago(Reuters) - AstraZeneca Plc said on Wednesday its experimental drug capivasertib was able to help...
Novartis, helped by cost cuts, raises full-year outlook
Reuters via Yahoo Finance· 1 year agoFRANKFURT (Reuters) -Novartis on Tuesday raised its full-year earnings outlook following cost cuts,...
